Effect of therapeutic hypothermia vs δ-opioid receptor agonist on post resuscitation myocardial function in a rat model of CPR
Sung Phil Chung,Feng-Qing Song,Tao Yu,Yinlun Weng,Shijie Sun,Max Harry Weil,Wanchun Tang
DOI: https://doi.org/10.1016/j.resuscitation.2010.11.010
IF: 6.251
2011-01-01
Resuscitation
Abstract:Methods Ventricular fibrillation (VF) was induced in 15 male Sprague–Dawley rats. After 8 min of untreated VF, cardiopulmonary resuscitation was performed for 8 min before defibrillation. Animals were randomized to three groups of five: (a) normothermia; (b) hypothermia (32 °C); and (c) normothermia with DADLE intravenous infusion (1 mg/kg h −1 ). Hypothermia and drug infusion were started after successful defibrillation. Myocardial functions, including cardiac output (CO), left ventricular ejection fraction (LVEF), and myocardial performance index (MPI) were measured echocardiographically together with duration of survival. Results The 72-h survival was significantly greater in the hypothermic group than in both DADLE and normothermic group ( p = 0.02). However, the survival time of the DADLE treated animals was significantly longer than that of the normothermia group (51.8 ± 18.9 vs 18.8 ± 10.1 h, p < 0.01). DADLE group showed significantly better CO (PR 60 min, p = 0.049), better LVEF (PR 60 min, p = 0.044; PR 240 min, p < 0.001) and lower MPI (PR 60 min, p = 0.043; PR 240 min, p = 0.045) than normothermic group. Hypothermia group also showed significantly better CO (PR 60 min, p = 0.044; PR 240 min, p = 0.007), better LVEF (PR 60 min, p = 0.001; PR 240 min, p < 0.001) and lower MPI (PR 60 min, p = 0.003; PR 240 min, p = 0.012) than the normothermic group. Conclusions DADLE attenuated post resuscitation myocardial dysfunction and increased short term survival time. However, the 72-h survival in the DADLE group was less than that in the hypothermia group. Keywords Cardiac arrest Cardiopulmonary resuscitation Delta opioid receptor Hypothermia 1 Introduction Cardiac arrest and cardiopulmonary resuscitation (CPR) are associated with global myocardial ischemia and reperfusion injury most often with fatal outcome. Mild therapeutic hypothermia is now accepted as a standard therapeutic intervention for post resuscitation care. Although the active mechanisms are not fully understood, therapeutic hypothermia reduces metabolic rate and therefore oxygen consumption. Cerebral metabolism decreases by 6–10% for each 1 °C reduction in body temperature and it prevents or mitigates some destructive processes such as production of free radicals, mitochondrial injury, cell membrane leakage, and ion pump dysfunction. 1 Ischemic preconditioning has played an important role in the mechanisms of endogenous protective mechanisms against ischemia of the heart and brain. 2,3 Recently, pharmacologically induced postconditioning with opioids, which is proposed to involve δ-opioid receptor (DOR) activation, has been suggested as the potential application in clinical practice for post resuscitation care. 4 One of the DOR agonists, d -Ala 2 - d -Leu 5 enkephalin (DADLE), has been found to reproduce the systemic hibernation in animals and is often referred to as the hibernation induction trigger. 5 Systemic infusion of DADLE produces a 30–40% reduction in the metabolic rate. 6 It has been shown that DADLE limits myocardial infarct size in models of cardiac ischemia and reperfusion. 7,8 Neuroprotective properties of DADLE are also observed in multiple scenarios, including global brain ischemia 9 or pharmacologically induced brain injury. 10,11 It has also been reported to be protective against ischemia in the intestinal, 12 liver 13 and lung 14 tissues. Recent reports have found that pretreatment with DADLE attenuates hippocampal CA1 neuronal damage from 8 min of asphyxial cardiac arrest in rats. 15 However, its effect as a pharmacological postconditioning agent has not yet been investigated in comparison with therapeutic hypothermia in the post resuscitation period. We investigated whether DADLE improves resuscitation outcomes equivalent to hypothermia in a rat model of cardiac arrest. The hypothesis of this study is that the activation of DOR with DADLE has the same effect on post resuscitation myocardial function and 72-h survival rate as therapeutic hypothermia in a rat model of cardiac arrest and CPR. 2 Methods All animals received humane care in compliance with the Principles of Laboratory Animal Care formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee of the Weil Institute of Critical Care Medicine. 2.1 Animal preparation Studies were performed on fifteen male Sprague–Dawley rats, weighing between 450 and 550 g. The animals were fasted overnight except for free access to water and anesthetized by intraperitoneal injection of pentobarbital (45 mg/kg). Additional doses of 10 mg/kg were administered at hourly intervals to maintain anesthesia. The trachea was orally intubated with a 14-gauge cannula mounted on a blunt needle with a 145° angled tip (Abbocath-T, Abbott Hospital Products, North Chicago, IL). 16 End-tidal CO 2 (PetCO 2 ) was monitored continuously with a side stream infrared CO 2 analyzer (200, Instrumentation Laboratories, Lexington, MA) interposed between the tracheal cannula and the respirator. A 23-gauge PE catheter (PE-50, Becton Dickinson, Sparks, MD) was advanced through the left external jugular vein into the right atrium. Right atrial pressure was measured with reference to the midchest with a high-sensitivity pressure transducer (42584-01, Abbott Critical Care Systems, North Chicago, IL). A 4-Fr PE catheter (CPMS-401J, Cook Critical Care, Bloomington, IN) was advanced through the right external jugular vein into the right atrium. A precurved guide wire supplied with the catheter was then advanced through the catheter into the right ventricle until an endocardial electrocardiogram was confirmed. A PE-50 catheter was advanced through the left femoral artery into the thoracic aorta for measurement of aortic pressure. A PE-50 catheter was advanced through the left femoral vein into the inferior vena cava for drug infusion. A thermocouple microprobe 0.5 mm in diameter (9030-12-D-34, Columbus Instruments, Columbus, OH) was advanced from the right femoral artery into the descending thoracic aorta. Blood temperature was measured with this sensor. All catheters were flushed intermittently with saline containing 2.5 IU/mL of crystalline bovine heparin (Hospira Inc., Lake Forest, IL). The electrocardiograph lead II was continuously recorded. A heat lamp was used to maintain body temperature at 36.8 ± 0.5 °C. 2.2 Experimental procedure Fifteen minutes before ventricular fibrillation (VF) was induced, the animals were randomized into 3 groups of 5 by the closed envelope method: (a) normothermia with saline placebo (NT); (b) hypothermia with saline placebo (HT); and (c) normothermia with the δ-opioid receptor agonist, DADLE. Mechanical ventilation was initially established at a tidal volume of 0.65 mL/100 g of body weight and a frequency of 100 breaths/min with FiO 2 of 0.21. The tidal volume was then adjusted to maintain PetCO 2 between 35 and 40 mm Hg. A progressive increase in 60-Hz current to a maximum of 4 mA was then delivered to the right ventricular endocardium to induce VF. The current flow was continued for 3 min to preclude spontaneous reversal of VF and mechanical ventilation was discontinued. Precordial compression, with a depth of approximately 30% of the anterioposterior chest diameter at maximal compression, was begun 8 min after the onset of VF with a pneumatically driven mechanical chest compressor. 16 Coincident with the start of precordial compression, mechanical ventilation was resumed. The FiO 2 was increased to 1.0. Precordial compressions at a rate of 200/min were synchronized to provide a compression–ventilation ratio of 2:1 with equal compression–relaxation duration. Depth of compression was adjusted to maintain the coronary perfusion pressure (CPP) at 20–24 mm Hg. Resuscitation was attempted with up to three 2-J biphasic waveform countershocks (CodeMaster XL, Philips, Seattle, WA) 16 min after cardiac arrest and 8 min after the start of precordial compression. In unsuccessfully resuscitated animals, precordial compression was restarted and maintained for 30 s before a second sequence of electrical shocks. If necessary, this procedure was repeated twice. Restoration of spontaneous circulation (ROSC) was defined as the return of supraventricular rhythm with a mean aortic pressure of 50 mm Hg and above for a minimum of 5 min. For the hypothermia group, rapid external cooling was started immediately after ROSC with the aid of ice packs and an electrical fan. The target temperature was 31.8–32.2 °C at post resuscitation (PR) 10 min. Either saline placebo or 1 mg/kg h −1 of DADLE (Bachem Bioscience Inc., King of Prussia, PA) was injected intravenously at a rate of 0.2 mL/h with an infusion pump (MicroMacroXL, Abbott Laboratories, North Chicago, IL) from PR 10 min to PR 240 min ( Fig. 1 ). The infusion was administered at a dosage of 1 mg/kg h −1 for 4 h, according to our pilot experiments and previous studies. 8,17 Animals were monitored for a total of 4 h after resuscitation. After the panel of 4-h post resuscitation measurements and 4-h cooling procedures were completed, intravascular catheters were removed and wounds surgically sutured. The animals were then rewarmed passively and returned into their cages and observed for an additional 68 h. Neurologic deficit scores (NDS) which ranged from 0 (normal) to 100 (brain-dead) were obtained at PR 24, 48, and 72 h. 18 The animals were euthanized with an intraperitoneal injection of pentobarbital (150 mg/kg). At autopsy, organs were inspected for gross abnormalities, including evidence of traumatic injuries consequent to cannulation, airway management, or precordial compression. 2.3 Measurements Aortic and right atrial pressures, electrocardiogram lead II, and PetCO 2 values were continuously recorded on a personal computer-based data-acquisition system supported by WINDAQ software (DataQ, Akron, OH). CPP was calculated as the difference between aortic and time-coincident right atrial pressures in the interval between chest compressions. Arterial blood gas was measured by a blood gas analyzer (Stat Profile pHOx; NOVA Biochemical, Waltham, MA). Arterial blood lactate was also measured with a lactic acid analyzer (model 23L; Yellow Springs Instruments, Yellow Springs, OH). At 6 min after the start of precordial compression and at 60 and 240 min after resuscitation, this panel of measurements was repeated. Myocardial function was assessed with left ventricular ejection fraction (LVEF) and cardiac output (CO) using echocardiography (Model HD11XE, Philips Healthcare, Endover, MA) at baseline, PR 60 and 240 min. Parasternal long axis views were obtained and recorded to ensure that the mitral and aortic valves and the apex were visualized. Short axis views were recorded at the mid-papillary muscle level. Endocardial area tracings, using the leading edge method, were performed in 2D mode from digital images captured on cineloop to calculate end-diastolic and end-systolic LV areas. End-diastolic volume (EDV) and end-systolic volume (ESV) were calculated by a modified Simpson's method. Ejection fraction (EF) was then derived as EF = (EDV − ESV)/EDV × 100. In a five-chamber view image, the Doppler sample volume was positioned as close as possible to the valve cusps inside the ascending aorta. After evaluation of the aortic flows, cardiac output was calculated from aortic velocity spectra using the equation: CO = VTI × aortic cross-sectional area × heart rate, where VTI = area under the velocity spectrum (Velocity Time Integral). The myocardial performance index (MPI), which combines time intervals related to systolic and diastolic functions and reflecting the global cardiac function was also calculated using the formula ( a − b )/ b , where a = mitral closure-to-opening interval (time interval from cessation to onset of mitral inflow) and b = ET (aortic flow ejection time, obtained at the LV outflow tract). 19 2.4 Statistical analysis Normal distribution was confirmed with the Kolmogorov–Smirnov test. For measurements between groups, analysis of variance (ANOVA) and Scheffé’s multiple-comparison techniques were employed for scale variables. Comparisons between time-based measurements within each group were performed with repeated-measurement analysis of variance and Kaplan–Meier survival analysis. Survival rates were compared by Chi square test. For comparison of NDS, Kruskal–Wallis test and Mann–Whitney test were used. Measurements were reported as mean ± SD values. All the statistical analyses were performed with the use of SPSS version 15.0 (SPSS, Chicago, IL). All statistical tests were 2-tailed, and a p value less than 0.05 was considered to be statistically significant. 3 Results No differences in baseline status were observed among the three groups except a low baseline lactate level in normothermic control group ( Table 1 ). The CPP, arterial temperature, blood gas variables and lactate levels at 6 min of CPR were not statistically different ( Table 1 , Fig. 1 ). All animals were successfully resuscitated. The average number of defibrillations given to achieve ROSC was 1.4 ± 1.4 times (range, 1–6) and did not differ significantly among the three groups. The aortic temperature was decreased to 32.0 ± 0.5 °C in the hypothermic group vs. 36.9 ± 0.1 °C in the DADLE group or 36.8 ± 0.4 °C in the normothermic group at 10 min after ROSC ( Fig. 1 ). The post resuscitation myocardial dysfunctions such as decreased CO and LVEF, and increased MPI were observed at 60 and 240 min after resuscitation ( Fig. 2 ). DADLE group showed significantly better CO (PR 60 min, p = 0.049), better LVEF (PR 60 min, p = 0.044; PR 240 min, p < 0.001) and lower MPI (PR 60 min, p = 0.043; PR 240 min, p = 0.045) than the normothermic group. Hypothermia group also showed significantly better CO (PR 60 min, p = 0.044; PR 240 min, p = 0.007), better LVEF (PR 60 min, p = 0.001; PR 240 min, p < 0.001) and lower MPI (PR 60 min, p = 0.003; PR 240 min, p = 0.012) than the normothermic group. There were no differences in myocardial functions between DADLE and hypothermia group. Mean arterial pressures of the animals in the hypothermic group were higher than that in the normothermic group 30 min post resuscitation. Heart rate and PetCO 2 values after resuscitation were not significantly different among the groups. There were no significant differences in arterial lactate concentration and blood gas variables such as partial pressure of oxygen and carbon dioxide. The average survival time of the DADLE treated animals was 51.8 ± 18.9 h which was greater than that of the normothermic control group (18.8 ± 10.1 h, p < 0.01) but was insignificantly lower than that of the hypothermic group (68.6 ± 7.6, p = 0.17). However, the 72-h survival rate was significantly greater in hypothermic group than both the DADLE and normothermic groups ( Table 2 ). The survival curves are compared in Fig. 3 . The NDS at 24 h after resuscitation were not statistically different among three groups and the NDS at 48 and 72 h were also not significantly different between hypothermia and DADLE groups ( Table 2 ). No gross abnormalities were observed at necropsy in any of the study groups. 4 Discussion The present study demonstrated that the DOR agonist, DADLE, when administered during reperfusion after successful CPR, decreased post resuscitation myocardial dysfunction and increased short term survival when compared with the normothermic control group. However, the effect of DADLE on 72-h survival was inferior to the therapeutic hypothermia. In this study, both the DADLE group and hypothermia group had reduced severity of myocardial dysfunction at 60 min and 240 min after resuscitation. Our results were consistent with a previous study which indicated that the severity of myocardial damage and dysfunction after CPR was reduced when hypothermia was applied. Meybohm et al. 20 reported a reduction in immune cell infiltration, apoptosis, IL-1b and IL-6 mRNA up-regulation, and decreased matrix metalloproteinase-9 activity in the ischemic myocardium after treatment with mild hypothermia. Previous studies have demonstrated that DADLE reduces myocardial infarct size in models of cardiac ischemia and reperfusion. 7,8 Studies utilizing selective synthetic opioid receptor agonists and antagonists suggest that the cardioprotection of DADLE appears to be preferentially mediated through δ-1 rather than δ-2 opioid receptors. 21 Delta-2 opioid receptor agonists have been known to potentially induce a hibernation-like state of metabolic depression and retardation of the anaerobic glycolytic pathway that increases the levels of circulating lactate. 22 There were a few studies to address the effect of DADLE in cardiac arrest model. In a deep hypothermic cardiac arrest model, DADLE showed no effect on survival or neurological function. 23 However, intracerebroventricularly pretreated DADLE showed attenuated hippocampal neuronal damage after 8 min of asphyxia cardiac arrest in rat. 15 This controverting results seemed to be derived from different severities of insult. Iwata et al. 24 reported that the survival of hippocampal CA3 neurons was improved after 6–8 min of forebrain ischemia after DADLE administration while such protective effect was not reproduced when the ischemic time was increased to 10 min. They interpreted the result that the insult after 10 min of global ischemia might exceed the capacity of DADLE-induced protection. Therefore we chose an 8-min VF cardiac arrest model to address the effect of DADLE. Even though most studies used DADLE to investigate the preconditioning effect which is given minutes to hours before ischemia, we started DADLE administration at 10 min after successful resuscitation. Since pretreatment would be clinically irrelevant in the setting of cardiac arrest and resuscitation, pharmacological postconditioning is more relevant in the post cardiac arrest setting. Studies in settings of regional myocardial ischemia have demonstrated that DOR agonists reduced myocardial infarct size when given immediately before or after reperfusion. Förster et al. 7 reported that DADLE protected against myocardial infarction when given at onset of reperfusion in an isolated rabbit heart model. When a single intravenous dose of either fentanyl or BW373U86 was given prior to ischemia, immediately prior to reperfusion or 10 s after reperfusion, the equal protective effects were observed. 25–27 In the present study, DADLE was administrated by continuous venous infusion. Although previous studies have used various methods for the administration of DADLE, including intraperitoneal, 9–11,24,28 intravenous bolus 8 or intracerebroventricular, 15,29 the intravenous route may be the most applicable and ideal means in the post resuscitation setting. We used continuous infusion rather than bolus injection because the half life of DADLE is less than 5 min when a 1 mg/kg bolus is injected intravenously into rats. 30 We did not observe any arrhythmia or hemodynamic instability during DADLE infusion. Both the hypothermic group and the DADLE treated group showed improved survival time compared with that of the normothermic group ( Fig. 3 ). This may have resulted from improved myocardial function after resuscitation. However, the 72-h survival rate was lower in the DADLE treated group compared with the hypothermic group. The DADLE treated animals showed a hibernation-like appearance in that they did not eat or move at all during the post resuscitation period. This may be one of the reasons for the apparent survival difference between the two groups. The neuroprotective effect of DADLE in this study could not be concluded. Although DOR was reported to play a crucial role in neuroprotection in a hypoxic environment, there were controversial reports for the effect of DADLE. Several studies using intraperitoneal DADLE showed beneficial effect in focal cerebral ischemia 9,28 or drug induced brain injury model, 14–16 while other studies reported that DADLE has no neuroprotective effect. 23,31 This study has several limitations. First, we did not confirm whether the cardioprotective effect of DADLE may be inhibited by the DOR antagonist. Second, we could not confirm the association of survival and myocardial function because the measurements of myocardial functions were limited to only 4 h after resuscitation. Third, we used only a subjective neurological outcome measurement, NDS. Moreover, it was not appropriately compared after 24 h of resuscitation because many animals were dead before their scheduled necropsy time points. Finally, blinding the investigators was not possible throughout the experiment due to use of the cooling technique. 5 Conclusion DADLE as well as therapeutic hypothermia attenuated post resuscitation myocardial dysfunction and increased short term survival compared with the normothermic control group. However, the 72-h survival was less optimal than that of therapeutic hypothermia in this rat model of cardiac arrest. Conflicts of interest statement The authors have no conflicts of interest to declare. Acknowledgement This study was supported in-house by the Weil Institute of Critical Care Medicine, Rancho Mirage, CA. Appendix A Supplementary data References 1 K.H. Polderman Mechanisms of action, physiological effects, and complications of hypothermia Crit Care Med 37 2009 S186 202 2 Z.Q. Zhao J.S. Corvera M.E. Halkos Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H579 H588 3 J.Y. Wang J. Shen Q. Gao Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats Stroke 39 2008 983 990 4 G.T. Wong R. Li L.L. Jiang M.G. Irwin Remifentanil post-conditioning attenuates cardiac ischemia–reperfusion injury via kappa or delta opioid receptor activation Acta Anaesthesiol Scand 25 2010 75 79 5 P.R. Oeltgen S.P. Nilekani P.A. Nuchols W.A. Spurrier T.P. Su Further studies on opioids and hibernation: delta opioid receptor ligand selectively induced hibernation in summer-active ground squirrels Life Sci 43 1988 1565 1574 6 C.L. Rosen A. Cote G.G. Haddad Effect of enkephalins on cardiac output and regional blood flow in conscious dogs Am J Physiol 256 1989 H1651 H1658 7 K. Förster A. Kuno N. Solenkova S.B. Felix T. Krieg The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation Am J Physiol Heart Circ Physiol 293 2007 H1604 H1608 8 D.C. Sigg J.A. Coles Jr. W.J. Gallagher P.R. Oeltgen P.A. Iaizzo Opioid preconditioning: myocardial function and energy metabolism Ann Thorac Surg 72 2001 1576 1582 9 C.V. Borlongan T. Hayashi P.R. Oeltgen T.P. Su Y. Wang Hibernation-like state induced by an opioid peptide protects against experimental stroke BMC Biol 7 2009 31 10 C.V. Borlongan T.P. Su Y. Wang Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons Neuroreport 11 2000 923 926 11 T. Hayashi H. Hirata M. Asanuma Delta opioid peptide ( d -Ala2, d -Leu5) enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53 Synapse 39 2001 305 312 12 R.J. Tubbs W.A. Porcaro W.J. Lee Delta opiates increase ischemic tolerance in isolated rabbit jejunum Acad Emerg Med 9 2002 555 560 13 K. Yamanouchi K. Yanaga S. Okudaira S. Eguchi J. Furui T. Kanematsu ( d -Ala2, d -Leu5) enkephalin (DADLE) protects liver against ischemia–reperfusion injury in the rat J Surg Res 114 2003 72 77 14 G. Wu F. Zhang R.K. Salley J.N. Diana T.P. Su S. Chien Delta opioid extends hypothermic preservation time of the lung J Thorac Cardiovasc Surg 111 1996 259 267 15 C.J. Gao J.P. Li W. Wang Effects of intracerebroventricular application of the delta opioid receptor agonist ( d -Ala2, d -Leu5) enkephalin on neurological recovery following asphyxial cardiac arrest in rats Neuroscience 168 2010 531 542 16 W. Tang M.H. Weil S. Sun K ATP channel activation reduces the severity of postresuscitation myocardial dysfunction Am J Physiol Heart Circ Physiol 279 2000 H1609 H1615 17 Y. Ikeda T. Miura J. Sakamoto Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by delta-opioid receptor activation Basic Res Cardiol 101 2006 418 426 18 R.W. Neumar N.G. Bircher K.M. Sim Epinephrine and sodium bicarbonate during CPR following asphyxial cardiac arrest in rats Resuscitation 29 1995 249 263 19 C. Tei New non-invasive index for combined systolic and diastolic ventricular function J Cardiol 26 1995 135 136 20 P. Meybohm M. Gruenewald M. Albrecht Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling PLoS One 4 2009 e7588 21 J. Huh G.J. Gross H. Nagase B.T. Liang Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels Am J Physiol Heart Circ Physiol 280 2001 H377 H383 22 M. Rutten M. Govindaswami P. Oeltgen J.S. Sonneborn Post-treatment with the novel deltorphin E, a delta2-opioid receptor agonist, increases recovery and survival after severe hemorrhagic shock in behaving rats Shock 29 2008 42 48 23 T. Drabek F. Han R.H. Garman Assessment of the delta opioid agonist DADLE in a rat model of lethal hemorrhage treated by emergency preservation and resuscitation Resuscitation 77 2008 220 228 24 M. Iwata S. Inoue M. Kawaguchi M. Nakamura N. Konishi H. Furuya Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia Br J Anaesth 99 2007 538 546 25 M.J. Watson J.D. Holt S.J. O’Neill ARD-353 (4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid), a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects J Pharmacol Exp Ther 316 2006 423 430 26 E.R. Gross J.N. Peart A.K. Hsu J.A. Auchampach G.J. Gross Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway Am J Physiol Heart Circ Physiol 288 2005 H2744 H2749 27 E.R. Gross G.J. Gross Ligand triggers of classical preconditioning and postconditioning Cardiovasc Res 70 2006 212 221 28 Y. Yang X. Xia Y. Zhang Delta-opioid receptor activation attenuates oxidative injury in the ischemic rat brain BMC Biol 7 2009 55 29 D.S. Su Z.H. Wang Y.J. Zheng Y.H. Zhao X.R. Wang Dose-dependent neuroprotection of delta opioid peptide ( d -Ala2, d -Leu5) enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats Neurosci Lett 423 2007 113 117 30 J.Z. Yang W. Chen R.T. Borchardt In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H–Tyr- d -Ala-Gly-Phe- d -Leu–OH (DADLE), and its cyclic prodrugs J Pharmacol Exp Ther 303 2002 840 848 31 M. Iwata S. Inoue M. Kawaguchi Delta opioid receptors stimulation with ( d -Ala2, d -Leu5) enkephalin does not provide neuroprotection in the hippocampus in rats subjected to forebrain ischemia Neurosci Let 414 2007 242 246